Medical Device | May 05, 2026
Microbot Medical expands LIBERTY Robotic System commercial rollout
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment
Tamir brings more than 20 years of experience in the medical technology sector
The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
Subscribe To Our Newsletter & Stay Updated
